Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical comparative study of dry eye before and after oral administration of a1A adrenergic receptor inhibitor (silodosin)
ChiCTR2300069351Phase 4Recruiting
- Sponsor
- Qingdao Eye Hospital of Shandong First Medical University
- Start
- Mar 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in dry eye syndrome (DED), sponsored by Qingdao Eye Hospital of Shandong First Medical University. Primary endpoints: Shirmer test I, Ocular Surface Disease Index and 1 more. Started Mar 2023; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2300069351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069351.